| 摘要 |
The present invention provides an oral disintegrating film formulation comprising: tadalafil as an active ingredient; and a combination of fluran and polyvinylpyrrolidone as a film forming agent. The oral disintegrating film formulation of the present invention does not exhibit buccal absorption, and can be formulated so as to exhibit bioequivalence to a tadalafil-containing tablet. In addition, the oral disintegrating film formulation of the present invention exhibits good stability. |
